Genetic Polymorphism of Cytochrome P450 4F2, Vitamin E Level and Histological Response in Adults and Children with Nonalcoholic Fatty Liver Disease Who Participated in PIVENS and TONIC Clinical Trials
Shaminie J. Athinarayanan(Virtua Health), Naga Chalasani(Indiana University – Purdue University Indianapolis), Jean P. Molleston(Riley Hospital for Children), Wanqing Liu(Purdue University West Lafayette), Rongrong Wei(Purdue University West Lafayette), Maret G. Traber(Oregon State University), Katherine P. Yates(Johns Hopkins University), Min Zhang(Sichuan University), Shaochun Bai(Indiana University School of Medicine), Oscar W. Cummings(Indiana University Hospital)
Cited by 44
Related Papers
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
|Hepatology|2017|7.2k
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
|New England Journal of Medicine|2021|1.1k
Endpoints and clinical trial design for nonalcoholic steatohepatitis
|Hepatology|2011|757
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
|Clinical Gastroenterology and Hepatology|2018|593